Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.88-22.9339.0023.66644.34

What is the latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS is -4.88 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-4.88
Mar2024-22.93
Mar202339.00
Mar202223.66
Mar2021644.34

How is Core EBITDA Growth of BAFNA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.88
Negative
Mar2024 -22.93
Negative
Mar2023 39
64.84
Mar2022 23.66
-96.33
Mar2021 644.34 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹542.7 Cr 6.1% 46.3% 208.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹469,382.0 Cr 0.8% 7.3% 15.6% Stock Analytics
DIVIS LABORATORIES ₹194,375.0 Cr 1.9% 8.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,308.0 Cr 0.6% 12.6% 43.9% Stock Analytics
CIPLA ₹116,447.0 Cr 0.2% 6.3% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹102,106.0 Cr -1.8% -3.5% -3.4% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

6.1%

46.3%

208.4%

SENSEX

0.1%

0.7%

-6.6%


You may also like the below Video Courses